Determinants of contraceptive methods use after voluntary induced abortion at the Yaounde Central Hospital, Cameroon

Background: Abortion is the termination of pregnancy with expulsion of the product of conception before the age of fetal viability- 28 weeks. In Africa, 96% of abortions are unsafe and there is an estimated 1 death for 150 abortions. Few data are available in Cameroon on the determinants of contraception after a voluntary termination of pregnancy. The objective of this study to investigate the determinants of the use of contraceptive methods after a voluntary termination of pregnancy.Methods: The study was descriptive cross-sectional lasting 09 months in the gynecology and obstetrics unit of the Yaounde Central Hospital. We included women admitted to this unit who have already had at least one abortion. All women who did not give their consent were excluded. The data were entered and analyzed using the Epi-info software version 7.2.2.6. The tools used to express our results were the Student's and Whitney's test, the Wald test and the Odd ratios (OR) with their 95% confidence interval. The significance level was 5%.Results: Out of 139 participants, 86 (61.87%) had already used a modern contraceptive method after voluntary termination of pregnancy. The mean age was 27.13±6.16 years with extremes of 16 and 42 years. Being single and having unwanted pregnancies independently increased contraceptive method use after abortions.Conclusions: An intensification of campaigns for behaviour change and men's involvement would further improve the use of contraceptive methods after abortion

First delivery of a COVID-19 positive patient in Cameroon

Since its appearance in China in December 2019, COVID-19 which is caused by the SARS-CoV-2 virus has become a real global health problem. Pregnant women are not immune to this novel infection, which makes it difficult for proper management of pregnancy and childbirth. Authors present here the first case of childbirth in Cameroon of a 19-year-old adolescent tested positive for COVID-19